ABSTRACT
Denny walked into my office one day after the reports for Example 3.2 came out looking like he had been run over by a bus and dragged over hot coals. He had been (figuratively) when he reviewed the findings with senior management. They obviously did not like the implications for getting together a marketable formulation in time for filing with the FDA.
